Value of FDG-PET as a Supporting Biomarker for Dementia with Lewy Bodies at Stages of Early Dopaminergic Loss.

Autor: Beyer, L, Huber, M, Rauchmann, BS, Morbelli, S, Bruffaerts, R, Vandenberghe, R, Nicastro, N, Lemstra, AW, Garcia-Ptacek, S, Ochoa Figueroa, MA, Vöglein, J, Perneczky, R, Bartenstein, P, Ewers, M, Danek, A, Levin, J, Aarsland, D, Nobili, FM, Rominger, A, Brendel, M
Zdroj: NuclearMedicine / Nuklearmedizin; 2020, Vol. 59 Issue 2, p184-185, 2p
Databáze: Complementary Index